Characterization of thermal and rheological properties of zidovudine, lamivudine and plasticizer blends with ethyl cellulose to assess their suitability for hot melt extrusion.

The influence of antiretroviral drugs and plasticizers on the rheological and thermal characteristics of ethyl cellulose formulations intended for hot melt extrusion has been investigated. Antiretroviral drugs used were zidovudine and lamivudine, whilst plasticizers included triethylcitrate (TEC) and polyethylene glycol (PEG-6000). Physical mixtures containing ethyl cellulose with varying concentrations of drugs and plasticizers were characterized using differential scanning calorimetry (DSC) and parallel plate oscillatory rheometry. The viscosity of physical mixtures containing both drugs was lower than observed for pure ethyl cellulose, indicating that the drugs had a plasticizing effect. This was confirmed by lowering of the glass transition temperature (Tg) of ethyl cellulose. At the highest loading of 40% by weight, lamivudine appeared to become saturated within the polymer, causing an increase in viscosity and showing evidence of recrystallization upon cooling. Both TEC and PEG-6000 were found to lower the Tg of ethyl cellulose, although PEG-6000 recrystallized upon cooling which makes it unsuitable for use in the proposed controlled release formulations. Both plasticizers were also shown to reduce the viscosity of ethyl cellulose, more significantly so for TEC. The results indicate that ethyl cellulose formulations containing up to 40% by weight of zidovudine, not more than 30% by weight of lamivudine, with 5-10% by weight of TEC as the plasticizer are suitable for processing by hot melt extrusion.

[1]  Charles E. Martin,et al.  Pharmaceutical Applications of Hot-Melt Extrusion: Part I , 2007, Drug development and industrial pharmacy.

[2]  C. Viscoli,et al.  Zidovudine (AZT) for treatment of patients infected with human immunodeficiency virus type 1. An evaluation of effectiveness in clinical practice. , 1991, Archives of internal medicine.

[3]  L. D. Landro,et al.  Thermal and mechanical degradation during polymer extrusion processing , 2007 .

[4]  Allan F. M. Barton,et al.  CRC Handbook of solubility parameters and other cohesion parameters , 1983 .

[5]  J. Mcginity,et al.  Influence of plasticizers on the mechanical properties of pellets containing Eudragit® RS 30 D , 1997 .

[6]  D. T. Friesen,et al.  Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview. , 2008, Molecular pharmaceutics.

[7]  R. Chokshi,et al.  Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution. , 2005, Journal of pharmaceutical sciences.

[8]  D. Faulds,et al.  Lamivudine , 1999, Drugs.

[9]  Peter York,et al.  The use of solubility parameters in pharmaceutical dosage form design , 1997 .

[10]  P York,et al.  Solubility parameters as predictors of miscibility in solid dispersions. , 1999, Journal of pharmaceutical sciences.

[11]  D. Craig,et al.  The mechanisms of drug release from solid dispersions in water-soluble polymers. , 2002, International journal of pharmaceutics.

[12]  J. Breitenbach Melt extrusion: from process to drug delivery technology. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[13]  Jef Adriaensen,et al.  Hot stage extrusion of p-amino salicylic acid with EC using CO2 as a temporary plasticizer. , 2006, International journal of pharmaceutics.

[14]  John G. Lyons,et al.  Preparation of monolithic matrices for oral drug delivery using a supercritical fluid assisted hot melt extrusion process. , 2007, International journal of pharmaceutics.

[15]  Bruno C. Hancock,et al.  Characteristics and significance of the amorphous state in pharmaceutical systems. , 1997, Journal of pharmaceutical sciences.

[16]  J Dressman,et al.  Improving drug solubility for oral delivery using solid dispersions. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[17]  Eric Doelker,et al.  Evaluation of hot-melt extrusion as a new technique for the production of polymer-based pellets for sustained release capsules containing high loadings of freely soluble drugs , 1994 .

[18]  M. Hussain,et al.  Bioavailability enhancement of a COX-2 inhibitor, BMS-347070, from a nanocrystalline dispersion prepared by spray-drying. , 2005, Journal of pharmaceutical sciences.

[19]  B. Perissutti,et al.  Preparation of extruded carbamazepine and PEG 4000 as a potential rapid release dosage form. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[20]  T. Rades,et al.  Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. , 2001, International journal of pharmaceutics.

[21]  S. Broder,et al.  Plasma and cerebrospinal fluid pharmacokinetics of 3′‐azido‐3′‐deoxythymidine: A Novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases , 1987, Clinical pharmacology and therapeutics.

[22]  Chandra Vemavarapu,et al.  Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability. , 2007, International journal of pharmaceutics.

[23]  P. York,et al.  Shear and extensional rheology of hydroxypropyl cellulose melt using capillary rheometry. , 2009, Journal of pharmaceutical and biomedical analysis.

[24]  James S. Taylor,et al.  Ideal copolymers and the second‐order transitions of synthetic rubbers. i. non‐crystalline copolymers , 2007 .